Skip to content

Clinical trials

Cholangiocarcinoma trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Country / region: Taiwan Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20143
20154
20162
20174
20197
20202
20212
20222
20232
20243
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated8
Active, not recruiting5
Recruiting4
Not yet recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie2
Chang Gung Memorial Hospital2
EMD Serono Research & Development Institute, Inc.2
Eli Lilly and Company2
Merck Sharp & Dohme LLC2
National Health Research Institutes, Taiwan2
QED Therapeutics, a BridgeBio company2
ASLAN Pharmaceuticals1
AbGenomics B.V Taiwan Branch1
Alentis Therapeutics AG1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma35
Biliary Tract Neoplasms11
Stomach Neoplasms8
Carcinoma, Non-Small-Cell Lung7
Gallbladder Neoplasms6
Neoplasms6
Ovarian Neoplasms6
Bile Duct Neoplasms5
Breast Neoplasms5
Colorectal Neoplasms5

Trials

Showing 51 to 35 of 35. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.